Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $19.3200 (-4.97%) ($19.3200 - $19.3200) on Wed. Feb. 10, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.85% (three month average) | RSI | 59 | Latest Price | $19.3200(-4.97%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA advances 0.2% a day on average for past five trading days. | Weekly Trend | ATRA advances 3% a week on average for past two weeks. | Market Behavior | Normal for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(53%) ARKG(45%) IBB(45%) ARKK(44%) IWO(44%) | Factors Impacting ATRA price | ATRA will decline at least -1.925% in a week (0% probabilities). VIXM(-35%) VXX(-27%) UNG(-10%) UUP(-9%) TLT(-9%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.925% (StdDev 3.85%) | Hourly BBV | -1.7 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $20(-3.4%) | 10 Day Moving Average | $19.52(-1.02%) | 20 Day Moving Average | $19.17(0.78%) | To recent high | -26.6% | To recent low | 24.2% | Market Cap | $1.436b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |